eSense-Lab
Reverse-engineered Cannabis Terpene Profiles
Company Overview
Snapshot
Founded in April 2016, eSense-Lab operates with 1–10 employees. The company has raised $2.48 million across one funding round. A significant milestone was its debut on the ASX in February 2017.
Business overview
eSense-Lab is a pharmatech company focused on re-engineering the chemical composition of plants, primarily cannabis, for commercial applications. It utilizes advanced technologies to deconstruct chemical profiles of rare or lucrative plants and then re-engineers them using alternate natural products to create virtual plant formulations. These plant-based products have commercial and medicinal applications, targeting multiple markets and mass consumer consumption within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Medical Cannabis.
Strategic signal
In April 2023, eSense-Lab ceased operations, indicating a significant shift in its business trajectory. This event signals to investors and innovation teams that the company is no longer an active entity in the market, highlighting the inherent risks and challenges within the pharmatech and cannabis-related industries.
Log in to access full profile ›Company Intelligence Q&A
- What is the primary focus of eSense-Lab?
- eSense-Lab specializes in reverse-engineering the chemical composition of plants, particularly cannabis, to reformulate them for various commercial and medicinal applications.
- When did eSense-Lab cease its operations?
- eSense-Lab ceased to operate in April 2023.
- What was a key financial milestone for eSense-Lab?
- eSense-Lab debuted on the ASX in February 2017, raising $2.48 million in its initial public offering.
- Did eSense-Lab engage in any strategic partnerships for product development?
- In May 2020, eSense-Lab announced a joint venture with SeaLaria to produce antiviral hand sanitisers. Additionally, in June 2020, the company inked a deal with Wise Winery for terpenes-infused sanitisers.
- What was the company's status regarding its stock exchange listing?
- eSense-Lab was delisted from the ASX in August 2021.